Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US7183310B2 · kind B2 · utility
5Cited by
12References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 10, 2004 |
| Grant date | Feb 27, 2007 |
| Priority date | — |
| Expiry date | Sep 1, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A compound comprisingor a pharmaceutically acceptable salt or a prodrug thereof, having the groups described in detail herein is disclosed.Also disclosed herein are compounds comprisingor derivatives thereof, or pharmaceutically acceptable salts, tetrazoles, or prodrugs of compounds of the structure or derivatives thereof, said derivatives being described in detail herein.Also disclosed herein are methods of treating diseases or conditions, including glaucoma and elevated intraocular pressure. Compositions and methods of manufacturing medicaments related thereto are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.